Literature DB >> 1928297

Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment.

T Nakamura1, I Ebihara, Y Tomino, K Okumura, H Koide.   

Abstract

Perforin is one of the important cytolytic factors in cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. In this study, the authors examined perforin mRNA levels in the kidney, spleen, liver, lung, heart, and brain of NZB/W F1 lupus mice and NZW mice. Perforin mRNA levels in the kidney, spleen, liver, and lung of NZB/W F1 mice increased significantly with age, whereas those in the heart and brain of NZB/W F1 mice showed little change between 2 and 10 months of age. In all tissues examined in NZW, control mice perforin mRNA levels showed little change during the experimental period. In addition, the authors examined the effect of methylprednisolone (MPSL) on perforin gene expression in the tissues of NZB/W F1 mice. MPSL ameliorated the increase in perforin mRNA levels in the kidney, spleen, liver, and lung of NZB/W F1 mice. These findings suggest that perforin may contribute to tissue injuries in autoimmune lupus mice and that MPSL may be effective in lupus partly by decreasing perforin expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928297      PMCID: PMC1886315     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Perforin gene expression in granular lymphocyte proliferative disorders.

Authors:  K Oshimi; Y Shinkai; K Okumura; Y Oshimi; H Mizoguchi
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

2.  In vivo expression of perforin by natural killer cells during a viral infection. Studies on uveitis produced by herpes simplex virus type I.

Authors:  L H Young; C S Foster; J D Young
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

Review 3.  The immunology and pathology of NZB mice.

Authors:  J B Howie; B J Helyer
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

4.  Induction of perforin and serine esterases in a murine cytotoxic T lymphocyte clone.

Authors:  C C Liu; S V Joag; B S Kwon; J D Young
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

5.  Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells.

Authors:  A Kawasaki; Y Shinkai; Y Kuwana; A Furuya; Y Iigo; N Hanai; S Itoh; H Yagita; K Okumura
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

6.  Molecular cloning and chromosomal assignment of a human perforin (PFP) gene.

Authors:  Y Shinkai; M C Yoshida; K Maeda; T Kobata; K Maruyama; J Yodoi; H Yagita; K Okumura
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.

Authors:  M J Smyth; J R Ortaldo; W Bere; H Yagita; K Okumura; H A Young
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

8.  Expression of mRNAs for pore-forming protein and two serine esterases in murine primary and cloned effector lymphocytes.

Authors:  S V Joag; C C Liu; B S Kwon; W R Clark; J D Young
Journal:  J Cell Biochem       Date:  1990-05       Impact factor: 4.429

9.  Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.

Authors:  C C Liu; S Rafii; A Granelli-Piperno; J A Trapani; J D Young
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.

Authors:  M J Smyth; J R Ortaldo; Y Shinkai; H Yagita; M Nakata; K Okumura; H A Young
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.